Novo Holdings A/S 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-23 9:20 pm Sale | 2024-09-19 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 5,549,900 5.900% | -794,530 (-12.52%) | Filing |
| 2024-01-25 4:26 pm Purchase | 2024-01-23 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 6,344,430 7.400% | 272,727 (+4.49%) | Filing |
| 2023-06-28 4:17 pm Unchanged | 2023-06-19 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 6,071,703 9.600% | 0 (Unchanged) | Filing |
| 2022-09-30 4:47 pm Unchanged | 2022-09-27 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 6,071,703 9.600% | 0 (Unchanged) | Filing |
| 2022-09-16 2:27 pm Purchase | 2022-09-14 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 6,071,703 9.600% | 484,496 (+8.67%) | Filing |
| 2021-03-31 4:31 pm Purchase | 2020-03-25 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 5,587,207 11.400% | 5,587,207 (New Position) | Filing |